Huhn et al. were able to show specific cytotoxicity of the human angiogenin to CD30 overexpressing Hodgkin lymphoma-derived cell lines delivered by a CD30 ligand (CD30L) [43]. This evidence concerns the gene TNFRSF8 and Hodgkins lymphoma.